Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biolargo Inc (OP:BLGO)

0.2145 +0.0026 (+1.23%)
Streaming Delayed Price Updated: 9:48 AM EDT, May 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biolargo Inc

< Previous 1 2 3 4 5 Next >
BioLargo Q1 2025 Earnings Results Webcast and Conference Call on Thursday, May 15, 2025 - 4:30 PM Eastern Time
Via ACCESS Newswire
BioLargo Subsidiary Clyra Medical Advances Product Distribution Through a Series of Agreements
Via ACCESS Newswire
BioLargo's PFAS Solution Provides Dramatic Long-Term Cost Savings Compared with Incumbent Technologies
Via ACCESS Newswire
Innovation Helps This CleanTech Company Weather The Current Market
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Cleantech Innovator BioLargo Reports Record Revenues in 2024 Annual Report
Via ACCESS Newswire
BioLargo Provides 2024 Review and 2025 Outlook
Via ACCESSWIRE
BioLargo's Year-to-Date Revenues Up 80%
Via ACCESSWIRE
CleanTech Innovator Delivers Long-Range, Safe Battery Tech
CleanTech Innovator Delivers Long-Range, Safe Battery Tech 
Via News Direct
Innovation Helps This CleanTech Company Weather The Current Market
Via TheNewswire.com
AI & Technology Virtual Investor Conference: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Gabelli Funds to Host 11th Annual Waste & Sustainability Symposium Thursday, April 3, 2025
From Gabelli Funds
Via GlobeNewswire
BioLargo Achieves Record Quarterly Revenue of $5 Million for Second Quarter of 2024
Via ACCESSWIRE
AI & Technology Virtual Investor Conference Agenda Announced for April 3rd
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
BioLargo to Present at the AI & Technology Virtual Investor Conference April 3, 2025
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
BioLargo Engineering Increases Ongoing Revenue with Another Air Force Contract
Via ACCESSWIRE
Gabelli Funds to Host 11th Annual Waste & Sustainability Symposium Thursday, April 3, 2025
From Gabelli Funds
Via GlobeNewswire
BioLargo Year-End 2024 Earnings Results Webcast and Conference Call on Monday, March 31, 2025 - 4:00 PM Eastern Time
Via ACCESS Newswire
Gabelli Funds to Host 11th Annual Waste & Sustainability Symposium Thursday, April 3, 2025
From Gabelli Funds
Via GlobeNewswire
BioLargo Invited to Showcase PFAS Treatment Technology at Industry Leading Water Conference
Via ACCESS Newswire
BioLargo, Inc. CEO Dennis P. Calvert Appointed to U.S. Department of Commerce Environmental Technologies Trade Advisory Committee (ETTAC)
Via ACCESSWIRE
BioLargo Q3 2024 Earnings Results Webcast and Conference Call on Thursday, November 14, 2024 - 4:30 PM Eastern Time
Via ACCESSWIRE
BioLargo, Inc. to Present at November 21st Virtual Investor Summit Microcap Event
Via ACCESSWIRE
BioLargo Validates Key Performance Metrics of Its Cellinity Battery Energy Storage Technology
Via ACCESSWIRE
Gabelli Funds to Host 2nd Annual PFAS Symposium at The Harvard Club, New York, NY
From Gabelli Funds
Via GlobeNewswire
BioLargo to Host Ribbon-Cutting Event for Battery Pilot Manufacturing Facility
Via ACCESSWIRE
Gabelli Funds to Host 2nd Annual PFAS Symposium at The Harvard Club, New York, NY
From Gabelli Funds
Via GlobeNewswire
Clyra Medical Technologies, a Subsidiary of BioLargo, Appoints Dr. Steven J. Kavros as Chief Medical Officer
Via ACCESSWIRE
BioLargo Earnings Results Webcast and Conference Call on Wednesday, August 14, 2024 - 1:30 PM Pacific Time
Via ACCESSWIRE
BioLargo Subsidiary Clyra Medical Selects Keystone Industries to Support Manufacturing of its Medical Products
Via ACCESSWIRE
BioLargo Manufactures First Cellinity Battery Cells, a Safer Alternative to Lithium-ion
Via ACCESSWIRE
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.